Co-lead investigator, PRIMARY2 trial; Director of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney
Appears in 1 story
Active researcher and clinician in PSMA theranostics
Every year, roughly 750,000 men in the United States alone undergo prostate biopsies that turn out to be unnecessary. On March 13, 2026, researchers at the European Association of Urology Congress in London presented results from the PRIMARY2 trial showing that a scan using a molecule that binds to prostate cancer cells and makes them glow on imaging cut the need for biopsies nearly in half, without missing dangerous cancers.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
